12 Month Price Forecast For ADGM
Distance to ADGM Price Forecasts
ADGM Price Momentum
๐ค Considering Adagio Medical (ADGM)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 10, 2025 1:48 PM UTC
ADGM Analyst Ratings & Price Targets
Currently, there are no Wall Street analyst price targets or forecasts available for ADGM (Adagio Medical).
ADGM is currently trading at $1.15. Without active analyst coverage, investors should conduct thorough independent research and consider multiple data points beyond price targets when evaluating this stock for their portfolio.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ADGM Analyst Consensus
ADGM Price Target Range
Latest ADGM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ADGM.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
Stocks Similar to Adagio Medical Holdings, Inc Common Stock
The following stocks are similar to Adagio Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Adagio Medical Holdings, Inc Common Stock (ADGM) Financial Data
Adagio Medical Holdings, Inc Common Stock has a market capitalization of $17.69M with a P/E ratio of -0.4x. The company generates $399,000 in trailing twelve-month revenue with a -335.3% profit margin.
Revenue growth is +109.9% quarter-over-quarter, while maintaining an operating margin of -2,621.7% and return on equity of +28.6%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Adagio Medical Holdings, Inc Common Stock (ADGM) Company Overview
About Adagio Medical Holdings, Inc Common Stock
Develops ablation technologies for cardiac arrhythmias.
The company focuses on creating and commercializing advanced medical devices specifically designed for the treatment of various cardiac arrhythmias. It generates revenue through the sale of its innovative catheter products and accessories, catering to a growing market in cardiac care.
Founded in 2011 and based in Laguna Hills, California, Adagio Medical Holdings, Inc. aims to address significant medical needs in the field of cardiology, particularly for conditions like atrial fibrillation and ventricular tachycardia. Its product offerings include specialized cryoablation catheters, which represent cutting-edge technology in cardiac treatment.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
87
CEO
Mr. Olav B. Bergheim
Country
United States
IPO Year
2024
Website
adagiomedical.comAdagio Medical Holdings, Inc Common Stock (ADGM) Latest News & Analysis
Adagio Medical Holdings announced the departure of CEO Olav Bergheim, effective December 13, 2024, and appointed Todd Usen as the new CEO and Director.
Leadership changes can impact company strategy and performance, influencing investor confidence and stock volatility. New CEO Todd Usen's track record will be closely evaluated for future growth prospects.
Adagio Medical Reports Third Quarter 2024 Results
2 months agoAdagio Medical Holdings reported Q3 2024 revenue of $185K, up from $41K in Q3 2023, and secured CMS coverage in September 2024.
Adagio Medical's revenue growth and secured CMS coverage signal improved market positioning and potential for increased sales, impacting future profitability and investor sentiment.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) CEO Olav Bergheim will present at the Stifel 2024 Healthcare Conference on November 18 at 9:45 a.m. ET. A webcast will be available for access.
CEO presentations can signal company direction and potential growth, influencing stock performance. Investors may seek insights into Adagio Medical's innovations and market positioning during this event.
Adagio Medical Holdings has completed the first procedures in its FDA Pivotal IDE study for the VT Cryoablation System, conducted by leading doctors at Vanderbilt University Medical Center.
The initiation of FDA pivotal study for Adagio's VT Cryoablation System signals potential advancements in cardiac treatment, which could enhance market position and investor confidence.
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
4 months agoAdagio Medical Holdings, Inc. (Nasdaq: ADGM) will sponsor and participate in the 19th Annual International Symposium on Ventricular Arrhythmias on October 11-12, 2024, in New York.
Adagio Medical's involvement in a key industry symposium highlights its commitment to innovation, potentially enhancing its market presence and attracting investor interest in its technologies.
Adagio Medical Provides Business Updates
5 months agoAdagio Medical Holdings, Inc. (Nasdaq: ADGM) has received CE Mark approval and launched its vCLASโข catheter and ULTC system for ventricular tachycardia in select European markets.
Adagio Medical's CE Mark approval and product launch in Europe enhance its market position and potential revenue growth, signaling strong prospects in the cardiac treatment sector.
Frequently Asked Questions About ADGM Stock
What is Adagio Medical Holdings, Inc Common Stock's (ADGM) stock forecast for 2025?
Analyst forecasts for Adagio Medical Holdings, Inc Common Stock (ADGM) are not currently available. The stock is trading at $1.15.
Is ADGM stock a good investment in 2025?
Analyst ratings for ADGM are not currently available. The stock is currently trading at $1.15. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for ADGM stock?
Price predictions from Wall Street analysts for ADGM are not currently available. The stock is trading at $1.15.
What is Adagio Medical Holdings, Inc Common Stock's business model?
The company focuses on creating and commercializing advanced medical devices specifically designed for the treatment of various cardiac arrhythmias. It generates revenue through the sale of its innovative catheter products and accessories, catering to a growing market in cardiac care.
What is the highest forecasted price for ADGM Adagio Medical Holdings, Inc Common Stock?
Price targets from Wall Street analysts for ADGM are not currently available. The stock is trading at $1.15.
What is the lowest forecasted price for ADGM Adagio Medical Holdings, Inc Common Stock?
Price targets from Wall Street analysts for ADGM are not currently available. The stock is trading at $1.15.
What is the overall ADGM consensus from analysts for Adagio Medical Holdings, Inc Common Stock?
Analyst ratings for ADGM are not currently available. The stock is trading at $1.15.
How accurate are ADGM stock price projections?
Stock price projections, including those for Adagio Medical Holdings, Inc Common Stock, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.